GUSELKUMAB

GUSELKUMAB was reported 38224 times

GUSELKUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT LEAKAGE 993 0.1768
1 DRUG DELIVERY SYSTEM MALFUNCTION 779 0.1522
2 DEVICE DEPLOYMENT ISSUE 1793 0.1402
3 NEEDLE ISSUE 2480 0.0851
4 GALLBLADDER ADENOCARCINOMA 6 0.0845
5 PRODUCT STORAGE ISSUE 265 0.0699
6 DEVICE DEFECTIVE 1207 0.0696
7 DELUSION OF PARASITOSIS 10 0.0637
8 REMOVAL OF INTERNAL FIXATION 9 0.0508
9 PSORIASIS AREA SEVERITY INDEX INCREASED 8 0.0485
10 LUNG ADENOCARCINOMA STAGE IV 18 0.0472
11 PRODUCT INFORMATION CONTENT COMPLAINT 13 0.0466
12 PRODUCT DOSE OMISSION ISSUE 12395 0.0421
13 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 8 0.0386
14 ACCIDENTAL EXPOSURE TO PRODUCT 3707 0.0359
15 NONALCOHOLIC FATTY LIVER DISEASE 7 0.0357
16 LIQUID PRODUCT PHYSICAL ISSUE 259 0.0355
17 PRODUCT LABEL ISSUE 239 0.0352
18 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 11 0.0350
19 GENERALISED PUSTULAR PSORIASIS 10 0.0345
20 PERICARDIAL EFFUSION MALIGNANT 6 0.0337
21 CONTRAINDICATION TO VACCINATION 6 0.0314
22 SYRINGE ISSUE 542 0.0309
23 PRODUCT OUTER PACKAGING ISSUE 24 0.0265
24 DEVICE MALFUNCTION 1772 0.0252
25 DEVICE ISSUE 2150 0.0239
26 PRODUCT TEMPERATURE EXCURSION ISSUE 121 0.0235
27 REACTIVE GASTROPATHY 9 0.0235
28 DEVICE LEAKAGE 1010 0.0233
29 INTESTINAL ANASTOMOSIS COMPLICATION 6 0.0221
30 PHYSICAL PRODUCT LABEL ISSUE 26 0.0218
31 ATOPY 6 0.0216
32 BLOOD URIC ACID DECREASED 10 0.0206
33 FROSTBITE 6 0.0200
34 PATERNAL EXPOSURE DURING PREGNANCY 17 0.0197
35 NAIL PSORIASIS 12 0.0194
36 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 45 0.0189
37 PSORIATIC ARTHROPATHY 756 0.0186
38 ERYTHRODERMIC PSORIASIS 15 0.0182
39 PSORIASIS 2311 0.0177
40 LATENT TUBERCULOSIS 34 0.0162
41 ADMINISTRATION SITE REACTION 6 0.0155
42 PRODUCT DESIGN ISSUE 11 0.0154
43 DRUG DELIVERY SYSTEM ISSUE 30 0.0152
44 PALMOPLANTAR PUSTULOSIS 8 0.0151
45 MANUFACTURING ISSUE 7 0.0151
46 HYPERTROPHY 8 0.0147
47 PRODUCT KNOWLEDGE DEFICIT 11 0.0141
48 PRODUCT STORAGE ERROR 1218 0.0139
49 GUTTATE PSORIASIS 11 0.0134
50 DACTYLITIS 13 0.0132
51 CIRRHOSIS ALCOHOLIC 6 0.0131
52 INJECTION RELATED REACTION 21 0.0127
53 NAIL BED BLEEDING 7 0.0123
54 ECZEMA NUMMULAR 6 0.0123
55 PUSTULAR PSORIASIS 42 0.0122
56 INFLAMMATORY PAIN 8 0.0118
57 INCORRECT DOSE ADMINISTERED BY PRODUCT 18 0.0112
58 CUTANEOUS T-CELL LYMPHOMA 14 0.0111
59 DERMATITIS EXFOLIATIVE GENERALISED 38 0.0109
60 PRODUCT CONTAINER SEAL ISSUE 19 0.0109
61 PRODUCT CLOSURE ISSUE 6 0.0108
62 BUNION OPERATION 6 0.0107
63 UNDERDOSE 769 0.0105
64 KERATOACANTHOMA 7 0.0102
65 DEVICE MECHANICAL ISSUE 140 0.0102
66 PRODUCT PACKAGING ISSUE 97 0.0102
67 PRODUCT LOT NUMBER ISSUE 22 0.0099
68 WRONG SCHEDULE 9 0.0094
69 AXIAL SPONDYLOARTHRITIS 8 0.0091
70 PRODUCT DOSE OMISSION 569 0.0087
71 ANTINUCLEAR ANTIBODY INCREASED 8 0.0083
72 ANTIBIOTIC THERAPY 8 0.0082
73 TINEA INFECTION 9 0.0081
74 PRODUCT ADMINISTRATION ERROR 164 0.0081
75 LOCAL REACTION 6 0.0081
76 DEVICE FAILURE 117 0.0077
77 VITILIGO 18 0.0077
78 COCCIDIOIDOMYCOSIS 9 0.0075
79 PRODUCT COMPLAINT 189 0.0075
80 SKIN STRIAE 11 0.0074
81 SHOULDER FRACTURE 12 0.0073
82 DRUG SPECIFIC ANTIBODY 10 0.0073
83 THERAPEUTIC PRODUCT EFFECT DECREASED 320 0.0071
84 POOR QUALITY PRODUCT ADMINISTERED 74 0.0070
85 SKIN PLAQUE 59 0.0070
86 DEVICE OCCLUSION 92 0.0065
87 MALIGNANT MELANOMA IN SITU 8 0.0065
88 PULPITIS DENTAL 6 0.0064
89 PUSTULE 15 0.0063
90 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1118 0.0062
91 ABDOMINAL SYMPTOM 5 0.0062
92 METABOLIC SURGERY 7 0.0062
93 LOWER RESPIRATORY TRACT INFECTION 279 0.0061
94 NECK SURGERY 14 0.0060
95 DILATED CARDIOMYOPATHY 6 0.0059
96 CONTRAINDICATION TO MEDICAL TREATMENT 9 0.0059
97 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 100 0.0058
98 ABSCESS DRAINAGE 5 0.0058
99 ENTHESOPATHY 9 0.0058
100 ALCOHOL WITHDRAWAL SYNDROME 5 0.0057
101 CARPAL TUNNEL DECOMPRESSION 6 0.0057
102 DEVICE DELIVERY SYSTEM ISSUE 155 0.0057
103 SELF-MEDICATION 23 0.0056
104 PRODUCT COLOUR ISSUE 28 0.0054
105 ENDOMETRIAL CANCER 12 0.0054
106 INJECTION SITE HAEMORRHAGE 430 0.0054
107 INCORRECT DOSE ADMINISTERED BY DEVICE 139 0.0053
108 INCORRECT DISPOSAL OF PRODUCT 17 0.0052
109 HEPATIC CIRRHOSIS 98 0.0052
110 FAECAL CALPROTECTIN INCREASED 16 0.0050
111 MYELITIS TRANSVERSE 7 0.0050
112 HEPATIC ENZYME INCREASED 337 0.0049
113 METABOLIC SYNDROME 8 0.0049
114 NOROVIRUS INFECTION 7 0.0048
115 SEBORRHOEIC DERMATITIS 8 0.0048
116 SHOULDER ARTHROPLASTY 13 0.0048
117 IGA NEPHROPATHY 8 0.0048
118 CHOLANGIOCARCINOMA 7 0.0047
119 HEPATOSPLENOMEGALY 12 0.0047
120 LUNG ADENOCARCINOMA 14 0.0046
121 TRANSITIONAL CELL CARCINOMA 6 0.0046
122 HEPATIC STEATOSIS 86 0.0046
123 COMPLICATION ASSOCIATED WITH DEVICE 66 0.0045
124 CARDIAC ABLATION 8 0.0045
125 MEGACOLON 7 0.0045
126 OPHTHALMIC HERPES ZOSTER 8 0.0044
127 SIALOADENITIS 6 0.0044
128 HERPES VIRUS INFECTION 25 0.0043
129 INJECTION SITE REACTION 297 0.0043
130 HIP SURGERY 23 0.0042
131 SQUAMOUS CELL CARCINOMA 40 0.0042
132 FUNGAL SKIN INFECTION 17 0.0042
133 HEPATIC MASS 8 0.0041
134 ACUTE ABDOMEN 6 0.0041
135 LOSS OF THERAPEUTIC RESPONSE 13 0.0041
136 THERAPEUTIC RESPONSE DECREASED 246 0.0041
137 HERPES SIMPLEX 26 0.0040
138 DERMATITIS PSORIASIFORM 8 0.0039
139 DIVERTICULAR PERFORATION 8 0.0039
140 LICHEN PLANUS 9 0.0039
141 JOINT DESTRUCTION 6 0.0039
142 BRONCHIAL DISORDER 6 0.0039
143 HEPATIC ENZYME ABNORMAL 19 0.0038
144 SCLERITIS 6 0.0037
145 COLON CANCER METASTATIC 6 0.0037
146 PEMPHIGOID 28 0.0037
147 SACROILIITIS 7 0.0037
148 THERAPY INTERRUPTED 264 0.0037
149 DEVICE PHYSICAL PROPERTY ISSUE 28 0.0037
150 SPINAL OPERATION 45 0.0036
151 SUSPECTED COVID-19 12 0.0036
152 PAPILLOMA VIRAL INFECTION 6 0.0036
153 VARICES OESOPHAGEAL 11 0.0036
154 COLITIS ULCERATIVE 162 0.0036
155 LIVER FUNCTION TEST INCREASED 77 0.0036
156 LIVER TRANSPLANT 13 0.0036
157 SPONDYLITIS 13 0.0036
158 SKIN DISORDER 119 0.0036
159 DECREASED IMMUNE RESPONSIVENESS 35 0.0036
160 THERAPY CESSATION 183 0.0036
161 TREATMENT DELAYED 6 0.0035
162 THROMBOPHLEBITIS 12 0.0034
163 PRODUCT DISPENSING ERROR 74 0.0034
164 ERYSIPELAS 17 0.0034
165 OTITIS MEDIA 11 0.0033
166 APPLICATION SITE HAEMORRHAGE 9 0.0033
167 B-CELL LYMPHOMA 11 0.0032
168 INFLAMMATORY MARKER INCREASED 16 0.0032
169 COVID-19 566 0.0032
170 FEAR OF INJECTION 23 0.0032
171 GASTRIC BYPASS 7 0.0032
172 MATERNAL EXPOSURE DURING BREAST FEEDING 13 0.0032
173 SPINAL FUSION SURGERY 13 0.0032
174 PRODUCT QUALITY ISSUE 435 0.0032
175 BLOOD CREATININE DECREASED 10 0.0032
176 INCORRECT DOSE ADMINISTERED 722 0.0032
177 MALIGNANT MELANOMA 42 0.0031
178 LIVER DISORDER 139 0.0031
179 TONSILLITIS 16 0.0031
180 CYTOMEGALOVIRUS COLITIS 7 0.0030
181 SARS-COV-2 TEST POSITIVE 40 0.0030
182 EXPOSURE DURING PREGNANCY 188 0.0030
183 ATYPICAL PNEUMONIA 9 0.0030
184 UPPER RESPIRATORY TRACT INFECTION 139 0.0030
185 DEFAECATION URGENCY 21 0.0030
186 CRANIOCEREBRAL INJURY 9 0.0030
187 RESPIRATORY TRACT INFECTION 77 0.0030
188 CHOLANGITIS SCLEROSING 6 0.0029
189 DEVICE USE ISSUE 51 0.0029
190 INJECTION SITE INJURY 16 0.0029
191 ALOPECIA AREATA 5 0.0028
192 SYMPTOM RECURRENCE 17 0.0028
193 THERAPY NON-RESPONDER 127 0.0028
194 PNEUMONIA VIRAL 9 0.0028
195 CELLULITIS 142 0.0028
196 SHOULDER OPERATION 12 0.0028
197 APPENDICECTOMY 10 0.0028
198 INJECTION SITE DISCHARGE 15 0.0028
199 JAW FRACTURE 6 0.0028
200 PYODERMA GANGRENOSUM 10 0.0028
201 ORAL HERPES 54 0.0028
202 EXPOSURE VIA BREAST MILK 11 0.0028
203 ILEOSTOMY 7 0.0027
204 DISSEMINATED TUBERCULOSIS 7 0.0027
205 SKIN INJURY 9 0.0027
206 SUBCUTANEOUS ABSCESS 13 0.0027
207 COVID-19 PNEUMONIA 32 0.0027
208 LIMB OPERATION 13 0.0027
209 KIDNEY INFECTION 53 0.0027
210 PRODUCT USE COMPLAINT 42 0.0027
211 DEVICE USE ERROR 92 0.0026
212 CHOLECYSTITIS ACUTE 15 0.0026
213 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
214 ANIMAL BITE 7 0.0026
215 ARTHRITIS 206 0.0026
216 BREAST SWELLING 7 0.0026
217 ABSCESS LIMB 11 0.0026
218 INVASIVE DUCTAL BREAST CARCINOMA 7 0.0026
219 BASAL CELL CARCINOMA 40 0.0026
220 CARDIAC OPERATION 22 0.0026
221 INJURY ASSOCIATED WITH DEVICE 52 0.0026
222 PNEUMONIA 825 0.0025
223 EXPOSURE VIA SKIN CONTACT 66 0.0025
224 SURGERY 148 0.0025
225 STREPTOCOCCAL INFECTION 14 0.0025
226 ARTHRALGIA 1040 0.0025
227 PULMONARY ALVEOLAR HAEMORRHAGE 14 0.0025
228 BLEPHARITIS 10 0.0025
229 LIVER ABSCESS 8 0.0025
230 CUTANEOUS VASCULITIS 9 0.0025
231 HAEMATOLOGICAL INFECTION 6 0.0025
232 INJECTION SITE NODULE 27 0.0025
233 IMMUNE SYSTEM DISORDER 32 0.0024
234 CANDIDA INFECTION 41 0.0024
235 OVERWEIGHT 13 0.0024
236 SKIN INFECTION 27 0.0024
237 DRUG DOSE OMISSION BY DEVICE 187 0.0024
238 AUTOIMMUNE THYROIDITIS 9 0.0024
239 INJECTION SITE RASH 73 0.0024
240 KNEE ARTHROPLASTY 50 0.0024
241 METASTASES TO LYMPH NODES 16 0.0024
242 TUBERCULIN TEST POSITIVE 6 0.0024
243 NONSPECIFIC REACTION 13 0.0024
244 DIARRHOEA HAEMORRHAGIC 22 0.0024
245 HEPATIC FIBROSIS 8 0.0023
246 HORDEOLUM 10 0.0023
247 BRAIN FOG 36 0.0023
248 ERYTHEMA NODOSUM 8 0.0023
249 PRODUCT DISTRIBUTION ISSUE 21 0.0023
250 CHOLANGITIS 14 0.0023
251 FUNGAL INFECTION 75 0.0022
252 INFLAMMATORY BOWEL DISEASE 22 0.0022
253 PRODUCT CONTAMINATION 8 0.0022
254 DIVERTICULITIS 62 0.0022
255 THERAPY CHANGE 22 0.0022
256 SKIN LESION 61 0.0022
257 WRONG PRODUCT ADMINISTERED 15 0.0022
258 INJECTION SITE SWELLING 168 0.0022
259 CONDITION AGGRAVATED 664 0.0022
260 MULTIPLE ALLERGIES 17 0.0022
261 HEPATITIS B 13 0.0022
262 AUTOIMMUNE HEPATITIS 15 0.0022
263 HEPATITIS C 26 0.0022
264 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 153 0.0021
265 COLON CANCER 32 0.0021
266 ONYCHOMADESIS 9 0.0021
267 THERAPEUTIC RESPONSE DELAYED 6 0.0021
268 APPENDICITIS 20 0.0021
269 KNEE OPERATION 21 0.0021
270 INTESTINAL STENOSIS 9 0.0021
271 PULMONARY TUBERCULOSIS 9 0.0021
272 FOLLICULITIS 22 0.0021
273 POST PROCEDURAL INFECTION 17 0.0021
274 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 423 0.0021
275 PRODUCT PHYSICAL ISSUE 42 0.0021
276 HYPERTONIC BLADDER 6 0.0021
277 CHAPPED LIPS 9 0.0021
278 ONYCHOMYCOSIS 9 0.0020
279 ANAL ABSCESS 11 0.0020
280 STRESS FRACTURE 11 0.0020
281 PHARYNGITIS STREPTOCOCCAL 22 0.0020
282 ANEURYSM 10 0.0020
283 INJECTION SITE INFLAMMATION 10 0.0020
284 UTERINE CANCER 16 0.0020
285 SQUAMOUS CELL CARCINOMA OF SKIN 12 0.0020
286 INJECTION SITE VESICLES 12 0.0020
287 FRUSTRATION TOLERANCE DECREASED 16 0.0020
288 GALLBLADDER OPERATION 8 0.0020
289 HIDRADENITIS 18 0.0020
290 CORONAVIRUS INFECTION 13 0.0020
291 DRUG INEFFECTIVE 2587 0.0020
292 PNEUMONIA BACTERIAL 18 0.0020
293 RECTAL CANCER 6 0.0020
294 DEMYELINATION 8 0.0020
295 PERIORBITAL SWELLING 11 0.0019
296 TREATMENT FAILURE 161 0.0019
297 LEG AMPUTATION 8 0.0019
298 TRANSAMINASES INCREASED 43 0.0019
299 SKIN LACERATION 21 0.0019
300 UMBILICAL HERNIA 9 0.0019
301 EAR INFECTION 51 0.0019
302 PRURITUS 736 0.0019
303 SKIN ATROPHY 11 0.0019
304 STAPHYLOCOCCAL INFECTION 63 0.0019
305 JOINT STIFFNESS 50 0.0019
306 INFECTION 274 0.0019
307 SKIN HAEMORRHAGE 28 0.0019
308 ARTHROPOD BITE 14 0.0019
309 OFF LABEL USE 1650 0.0019
310 ILLNESS 194 0.0019
311 ABSCESS 30 0.0019
312 HEPATIC PAIN 8 0.0019
313 INJECTION SITE PAIN 574 0.0019
314 MYASTHENIA GRAVIS 15 0.0019
315 LIVER FUNCTION TEST ABNORMAL 54 0.0019
316 ADVERSE EVENT 171 0.0019
317 CHEMOTHERAPY 7 0.0018
318 GASTRIC INFECTION 7 0.0018
319 PROCEDURAL COMPLICATION 14 0.0018
320 THERAPEUTIC PRODUCT INEFFECTIVE 7 0.0018
321 INGUINAL HERNIA 11 0.0018
322 DRUG ERUPTION 32 0.0018
323 LYME DISEASE 6 0.0018
324 MUSCLE RUPTURE 7 0.0018
325 SKIN MASS 12 0.0018
326 HERPES ZOSTER 103 0.0018
327 SINUSITIS 183 0.0018
328 FREQUENT BOWEL MOVEMENTS 48 0.0018
329 POSTOPERATIVE WOUND INFECTION 12 0.0018
330 PNEUMONIA FUNGAL 7 0.0018
331 TREATMENT NONCOMPLIANCE 97 0.0018
332 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
333 INSURANCE ISSUE 27 0.0018
334 INFLUENZA 196 0.0018
335 CHOLECYSTECTOMY 20 0.0017
336 SKIN FISSURES 34 0.0017
337 PHARYNGEAL SWELLING 17 0.0017
338 PRODUCT PRESCRIBING ERROR 41 0.0017
339 HEPATOCELLULAR CARCINOMA 13 0.0017
340 GOITRE 7 0.0017
341 POLYARTHRITIS 9 0.0017
342 ARTHRITIS BACTERIAL 7 0.0017
343 HIP ARTHROPLASTY 26 0.0017
344 NEOPLASM MALIGNANT 113 0.0017
345 INJECTION SITE BRUISING 135 0.0017
346 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
347 INJECTION SITE DISCOLOURATION 21 0.0017
348 BRONCHITIS 124 0.0017
349 ANKYLOSING SPONDYLITIS 22 0.0017
350 FACIAL BONES FRACTURE 6 0.0017
351 DERMATITIS CONTACT 19 0.0017
352 URTICARIA 278 0.0017
353 ADVERSE REACTION 22 0.0017
354 RENAL CELL CARCINOMA 8 0.0016
355 PRODUCT CONTAINER ISSUE 14 0.0016
356 INJECTION SITE URTICARIA 40 0.0016
357 FOOT OPERATION 8 0.0016
358 RASH 703 0.0016
359 LOCALISED INFECTION 39 0.0016
360 STENT PLACEMENT 13 0.0016
361 SCRATCH 17 0.0016
362 INFLAMMATION 83 0.0016
363 GASTROENTERITIS VIRAL 29 0.0016
364 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
365 JOINT EFFUSION 11 0.0016
366 ORAL CANDIDIASIS 21 0.0016
367 ECZEMA 83 0.0016
368 HYPOKINESIA 23 0.0016
369 INFLUENZA LIKE ILLNESS 130 0.0016
370 VARICOSE VEIN 8 0.0015
371 PRODUCT LABEL CONFUSION 9 0.0015
372 ORAL INFECTION 6 0.0015
373 SKIN CANCER 33 0.0015
374 TOOTH INFECTION 20 0.0015
375 FURUNCLE 12 0.0015
376 ROSACEA 7 0.0015
377 FEELING OF DESPAIR 7 0.0015
378 HYSTERECTOMY 13 0.0015
379 PRODUCT USE ISSUE 282 0.0015
380 NASOPHARYNGITIS 275 0.0015
381 BURSITIS 18 0.0015
382 VITAMIN B12 DEFICIENCY 6 0.0015
383 APPLICATION SITE DISCOLOURATION 6 0.0015
384 IMMUNOSUPPRESSION 13 0.0015
385 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
386 NEPHROLITHIASIS 67 0.0015
387 INJECTION SITE ERYTHEMA 181 0.0015
388 NODULE 19 0.0015
389 COLITIS 55 0.0014
390 CYST 18 0.0014
391 BACTERIAL INFECTION 27 0.0014
392 SWELLING OF EYELID 9 0.0014
393 INJECTION SITE PRURITUS 96 0.0014
394 MULTIPLE USE OF SINGLE-USE PRODUCT 8 0.0014
395 LYMPHOMA 22 0.0014
396 THROAT CANCER 6 0.0014
397 MUCOUS STOOLS 7 0.0014
398 SINUS CONGESTION 19 0.0014
399 GASTROINTESTINAL INFLAMMATION 11 0.0014
400 PRODUCT DISPENSING ISSUE 6 0.0014
401 UVEITIS 19 0.0014
402 CORONARY ARTERY BYPASS 8 0.0014
403 OCULAR ICTERUS 6 0.0014
404 BACK INJURY 15 0.0014
405 SKIN EXFOLIATION 116 0.0014
406 TOOTH ABSCESS 14 0.0014
407 VASCULITIS 16 0.0014
408 HEPATIC CANCER 33 0.0014
409 GINGIVAL SWELLING 6 0.0014
410 ADVERSE DRUG REACTION 122 0.0014
411 CHOLECYSTITIS 16 0.0013
412 ACCIDENT 16 0.0013
413 COLITIS ISCHAEMIC 9 0.0013
414 INJECTION SITE DISCOMFORT 14 0.0013
415 SENSITIVITY TO WEATHER CHANGE 7 0.0013
416 HEPATOMEGALY 13 0.0013
417 SCAB 15 0.0013
418 RASH PRURITIC 71 0.0013
419 PERICARDITIS 22 0.0013
420 FOOD POISONING 7 0.0013
421 GASTROENTERITIS 19 0.0013
422 LARGE INTESTINE POLYP 9 0.0013
423 ARTHRITIS INFECTIVE 6 0.0013
424 VIRAL INFECTION 43 0.0013
425 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
426 SCOLIOSIS 8 0.0013
427 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
428 ACUTE MYOCARDIAL INFARCTION 38 0.0013
429 LIMB INJURY 35 0.0013
430 CARPAL TUNNEL SYNDROME 18 0.0013
431 SWELLING 120 0.0013
432 HYPERSENSITIVITY 237 0.0013
433 SKIN TIGHTNESS 6 0.0013
434 HAND FRACTURE 9 0.0013
435 GESTATIONAL DIABETES 6 0.0013
436 HAEMATOCHEZIA 69 0.0012
437 HERNIA 24 0.0012
438 GUILLAIN-BARRE SYNDROME 6 0.0012
439 COLECTOMY 7 0.0012
440 NEUTROPHILIA 7 0.0012
441 SENSITIVE SKIN 9 0.0012
442 INJECTION SITE MASS 45 0.0012
443 INJECTION SITE EXTRAVASATION 15 0.0012
444 STAPHYLOCOCCAL SEPSIS 6 0.0012
445 URINARY TRACT INFECTION 207 0.0012
446 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 63 0.0012
447 INFUSION RELATED REACTION 80 0.0012
448 SKIN WARM 7 0.0012
449 EOSINOPHIL COUNT INCREASED 10 0.0012
450 BLISTER 67 0.0012
451 RASH ERYTHEMATOUS 57 0.0012
452 TENDON PAIN 9 0.0012
453 GASTROINTESTINAL DISORDER 106 0.0012
454 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
455 BURNING SENSATION 82 0.0012
456 HYPERTENSIVE CRISIS 13 0.0012
457 SCAR 20 0.0012
458 PAIN 716 0.0012
459 THYROID CANCER 14 0.0012
460 ARTHROPATHY 64 0.0012
461 ANAL FISTULA 6 0.0011
462 INTENTIONAL DOSE OMISSION 32 0.0011
463 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
464 INTESTINAL OBSTRUCTION 42 0.0011
465 IMPAIRED QUALITY OF LIFE 16 0.0011
466 DISABILITY 22 0.0011
467 GINGIVITIS 6 0.0011
468 ANAL INCONTINENCE 10 0.0011
469 SINUS DISORDER 22 0.0011
470 ABDOMINAL HERNIA 5 0.0011
471 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
472 THERAPEUTIC RESPONSE UNEXPECTED 49 0.0011
473 WRIST FRACTURE 13 0.0011
474 NERVE COMPRESSION 10 0.0011
475 SLUGGISHNESS 11 0.0011
476 NECROSIS 6 0.0011
477 HEADACHE 674 0.0011
478 MASS 15 0.0011
479 SUNBURN 8 0.0011
480 INTESTINAL PERFORATION 12 0.0011
481 CYSTITIS 34 0.0011
482 FISTULA 12 0.0011
483 OBESITY 17 0.0011
484 LIVER INJURY 26 0.0011
485 DERMATITIS 22 0.0010
486 PSEUDOMONAS INFECTION 9 0.0010
487 PRODUCT USE IN UNAPPROVED INDICATION 259 0.0010
488 NEOPLASM 12 0.0010
489 JOINT DISLOCATION 11 0.0010
490 MUSCLE STRAIN 9 0.0010
491 PAIN OF SKIN 28 0.0010
492 MOUTH SWELLING 6 0.0010
493 PARAESTHESIA ORAL 15 0.0010
494 SECRETION DISCHARGE 13 0.0010
495 WOUND 29 0.0010
496 FOOD ALLERGY 8 0.0010
497 DEVICE BREAKAGE 42 0.0010
498 BREAST CANCER 96 0.0010
499 ACNE 78 0.0010
500 NAIL DISORDER 9 0.0010
501 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 48 0.0010
502 AUTOIMMUNE DISORDER 10 0.0010
503 GROIN PAIN 9 0.0010
504 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
505 INJECTION SITE WARMTH 21 0.0010
506 HEPATIC FUNCTION ABNORMAL 38 0.0010
507 GAIT INABILITY 34 0.0010
508 HEPATITIS 26 0.0010
509 PNEUMOTHORAX 16 0.0010
510 HYPERTRANSAMINASAEMIA 7 0.0010
511 GASTROINTESTINAL INFECTION 9 0.0010
512 HOSPITALISATION 154 0.0010
513 GASTROINTESTINAL PAIN 11 0.0010
514 TYPE 1 DIABETES MELLITUS 6 0.0010
515 APPLICATION SITE REACTION 7 0.0010
516 LYMPHADENOPATHY 35 0.0010
517 FIBROMYALGIA 24 0.0010
518 SYSTEMIC LUPUS ERYTHEMATOSUS 35 0.0010
519 EYE INFECTION 11 0.0010
520 ERECTILE DYSFUNCTION 25 0.0010
521 ABORTION SPONTANEOUS 39 0.0010
522 ESCHERICHIA INFECTION 8 0.0010
523 TENDON RUPTURE 12 0.0010
524 RESPIRATORY DISORDER 29 0.0010
525 JOINT SWELLING 117 0.0010
526 ANKLE FRACTURE 15 0.0010
527 METASTASES TO LIVER 17 0.0010
528 PRODUCT PRESCRIBING ISSUE 21 0.0010
529 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
530 NIGHT SWEATS 31 0.0010
531 OROPHARYNGEAL PAIN 89 0.0010
532 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
533 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
534 MIGRAINE 91 0.0010
535 DISCOMFORT 58 0.0009
536 LUNG NEOPLASM MALIGNANT 39 0.0009
537 GOUT 17 0.0009
538 CHEST DISCOMFORT 97 0.0009
539 CONTUSION 91 0.0009
540 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
541 INJECTION SITE IRRITATION 12 0.0009
542 KETOACIDOSIS 7 0.0009
543 HEPATIC FAILURE 28 0.0009
544 EAR PAIN 18 0.0009
545 PYELONEPHRITIS 8 0.0009
546 SEASONAL ALLERGY 13 0.0009
547 PULMONARY THROMBOSIS 10 0.0009
548 SEPSIS 102 0.0009
549 BEDRIDDEN 12 0.0009
550 SKIN BURNING SENSATION 65 0.0009
551 CONCUSSION 7 0.0009
552 FOOT DEFORMITY 10 0.0009
553 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
554 PELVIC FRACTURE 7 0.0009
555 HYPERTHYROIDISM 13 0.0009
556 DIARRHOEA 578 0.0009
557 TOXIC SKIN ERUPTION 9 0.0009
558 BREAST MASS 6 0.0009
559 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
560 PERIPHERAL SWELLING 137 0.0009
561 RASH MACULAR 31 0.0009
562 IRRITABLE BOWEL SYNDROME 19 0.0009
563 NASAL CONGESTION 52 0.0009
564 EAR DISCOMFORT 9 0.0009
565 NEPHROTIC SYNDROME 6 0.0009
566 EXPIRED PRODUCT ADMINISTERED 29 0.0009
567 DERMATITIS ATOPIC 46 0.0009
568 RESPIRATION ABNORMAL 6 0.0009
569 OVARIAN CANCER 8 0.0009
570 LYMPHOPENIA 12 0.0008
571 BLOOD IRON DECREASED 10 0.0008
572 IMPAIRED WORK ABILITY 18 0.0008
573 EYE SWELLING 31 0.0008
574 POST PROCEDURAL COMPLICATION 16 0.0008
575 TYPE 2 DIABETES MELLITUS 28 0.0008
576 PANIC REACTION 6 0.0008
577 ABDOMINAL PAIN LOWER 21 0.0008
578 TOOTHACHE 15 0.0008
579 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
580 WOUND INFECTION 9 0.0008
581 MAJOR DEPRESSION 6 0.0008
582 PROSTATE CANCER 66 0.0008
583 VITAMIN D DEFICIENCY 8 0.0008
584 ALOPECIA 161 0.0008
585 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15 0.0008
586 RESPIRATORY TRACT CONGESTION 13 0.0008
587 BLOOD BILIRUBIN INCREASED 22 0.0008
588 SMALL INTESTINAL OBSTRUCTION 10 0.0008
589 NERVE INJURY 9 0.0008
590 PHARYNGITIS 10 0.0008
591 PULMONARY MASS 12 0.0008
592 SKIN DISCOLOURATION 37 0.0008
593 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
594 TOOTH EXTRACTION 10 0.0008
595 BRAIN INJURY 8 0.0008
596 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
597 HYPOAESTHESIA ORAL 12 0.0008
598 PRODUCT COMMUNICATION ISSUE 7 0.0008
599 FOOT FRACTURE 15 0.0008
600 PRODUCT AVAILABILITY ISSUE 18 0.0008
601 MUSCULOSKELETAL STIFFNESS 69 0.0008
602 FACIAL PAIN 7 0.0008
603 SWELLING FACE 51 0.0008
604 LIPASE INCREASED 6 0.0008
605 LIP SWELLING 26 0.0008
606 HEAVY MENSTRUAL BLEEDING 7 0.0008
607 APHTHOUS ULCER 6 0.0008
608 OSTEOMYELITIS 14 0.0008
609 LUPUS-LIKE SYNDROME 7 0.0008
610 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
611 ACUTE MYELOID LEUKAEMIA 12 0.0008
612 EYE DISCHARGE 8 0.0008
613 CEREBROVASCULAR ACCIDENT 130 0.0008
614 MYALGIA 130 0.0008
615 INTERSTITIAL LUNG DISEASE 37 0.0008
616 PANCREATIC CARCINOMA 22 0.0008
617 RETINAL DETACHMENT 7 0.0008
618 UROSEPSIS 7 0.0008
619 PANCREATITIS 40 0.0008
620 PANCREATITIS ACUTE 17 0.0008
621 OSTEOARTHRITIS 32 0.0008
622 RENAL PAIN 8 0.0008
623 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
624 QUALITY OF LIFE DECREASED 10 0.0007
625 RHINITIS 6 0.0007
626 SEPTIC SHOCK 32 0.0007
627 ASTHMA 83 0.0007
628 VISUAL IMPAIRMENT 91 0.0007
629 ABNORMAL LOSS OF WEIGHT 5 0.0007
630 RIB FRACTURE 15 0.0007
631 LOWER LIMB FRACTURE 14 0.0007
632 PYREXIA 251 0.0007
633 ACUTE CORONARY SYNDROME 6 0.0007
634 COUGH 202 0.0007
635 FACE OEDEMA 12 0.0007
636 LIGAMENT SPRAIN 7 0.0007
637 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
638 PAIN IN EXTREMITY 208 0.0007
639 ANAPHYLACTIC REACTION 39 0.0007
640 ABDOMINAL PAIN 164 0.0007
641 INABILITY TO AFFORD MEDICATION 7 0.0007
642 CHOLELITHIASIS 23 0.0007
643 HYPOTONIA 7 0.0007
644 HYPERTENSION 148 0.0007
645 MUSCULOSKELETAL DISCOMFORT 12 0.0007
646 HYPOACUSIS 30 0.0007
647 INJECTION SITE INDURATION 9 0.0007
648 CHILLS 81 0.0007
649 MUSCULOSKELETAL DISORDER 13 0.0007
650 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
651 MUSCLE TIGHTNESS 11 0.0007
652 FATIGUE 526 0.0007
653 RECTAL HAEMORRHAGE 29 0.0007
654 SWOLLEN TONGUE 21 0.0007
655 IMMUNODEFICIENCY 10 0.0007
656 IMPAIRED HEALING 22 0.0007
657 WEIGHT FLUCTUATION 7 0.0007
658 ABDOMINAL DISCOMFORT 112 0.0007
659 ATRIAL FIBRILLATION 65 0.0007
660 ERYTHEMA 137 0.0007
661 PHOTOSENSITIVITY REACTION 11 0.0007
662 THROAT TIGHTNESS 18 0.0007
663 RENAL DISORDER 31 0.0007
664 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
665 LIP DRY 6 0.0007
666 DIABETES MELLITUS 50 0.0007
667 JOINT INJURY 14 0.0007
668 BRAIN NEOPLASM 6 0.0007
669 UPPER LIMB FRACTURE 13 0.0007
670 DYSURIA 24 0.0007
671 ABDOMINAL PAIN UPPER 134 0.0007
672 RHINORRHOEA 42 0.0006
673 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
674 MYOCARDIAL INFARCTION 113 0.0006
675 CONJUNCTIVITIS 12 0.0006
676 ERYTHEMA MULTIFORME 6 0.0006
677 ABDOMINAL DISTENSION 67 0.0006
678 HYPOAESTHESIA 96 0.0006
679 OESOPHAGITIS 7 0.0006
680 FLANK PAIN 6 0.0006
681 SKIN REACTION 9 0.0006
682 CHEST PAIN 118 0.0006
683 FRACTURE 12 0.0006
684 THROMBOSIS 51 0.0006
685 PRODUCT PREPARATION ERROR 13 0.0006
686 MEDICATION ERROR 35 0.0006
687 LETHARGY 36 0.0006
688 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
689 HAEMORRHAGE 65 0.0006
690 RASH GENERALISED 16 0.0006
691 RHEUMATOID ARTHRITIS 70 0.0006
692 PLATELET COUNT INCREASED 8 0.0006
693 NERVOUSNESS 32 0.0006
694 ABNORMAL FAECES 5 0.0006
695 DRUG-INDUCED LIVER INJURY 19 0.0006
696 PANIC ATTACK 22 0.0006
697 BACK PAIN 140 0.0006
698 HEAD INJURY 19 0.0006
699 ROAD TRAFFIC ACCIDENT 25 0.0006
700 HYPOTHYROIDISM 19 0.0006
701 GASTRIC CANCER 15 0.0006
702 PARAESTHESIA 93 0.0006
703 ANGIOEDEMA 26 0.0006
704 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
705 PRODUCTIVE COUGH 28 0.0006
706 MUSCULOSKELETAL CHEST PAIN 9 0.0006
707 DRUG INTOLERANCE 56 0.0006
708 SNEEZING 13 0.0006
709 C-REACTIVE PROTEIN INCREASED 21 0.0006
710 CHROMATURIA 13 0.0006
711 TENDERNESS 6 0.0006
712 CEREBRAL INFARCTION 14 0.0006
713 TRANSFUSION 6 0.0006
714 BLOOD TEST ABNORMAL 8 0.0006
715 GENERALISED OEDEMA 7 0.0006
716 EYE PRURITUS 19 0.0006
717 ILEUS 7 0.0006
718 PERICARDIAL EFFUSION 13 0.0006
719 BODY HEIGHT DECREASED 6 0.0006
720 GALLBLADDER DISORDER 10 0.0006
721 HIP FRACTURE 18 0.0006
722 HYPERSOMNIA 16 0.0006
723 SYNOVITIS 10 0.0006
724 LEUKOCYTOSIS 10 0.0006
725 BIPOLAR DISORDER 6 0.0006
726 PREGNANCY 11 0.0005
727 HEPATIC CYTOLYSIS 7 0.0005
728 ASPIRATION 6 0.0005
729 EYE DISORDER 18 0.0005
730 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
731 DISEASE RECURRENCE 26 0.0005
732 MULTIPLE SCLEROSIS 26 0.0005
733 UNEVALUABLE EVENT 41 0.0005
734 SKIN ULCER 14 0.0005
735 FEELING HOT 33 0.0005
736 NEUROPATHY PERIPHERAL 51 0.0005
737 CARDIAC DISORDER 50 0.0005
738 GASTRITIS 14 0.0005
739 DRY SKIN 71 0.0005
740 FLUSHING 54 0.0005
741 PULMONARY CONGESTION 7 0.0005
742 WEIGHT DECREASED 148 0.0005
743 MALAISE 229 0.0005
744 CATARACT 31 0.0005
745 EXTRA DOSE ADMINISTERED 21 0.0005
746 MADAROSIS 6 0.0005
747 BLOOD CHOLESTEROL INCREASED 24 0.0005
748 GINGIVAL BLEEDING 7 0.0005
749 FAECES DISCOLOURED 11 0.0005
750 PULMONARY EMBOLISM 48 0.0005
751 ISCHAEMIC STROKE 9 0.0005
752 ANAPHYLACTIC SHOCK 13 0.0005
753 THIRST 9 0.0005
754 POLLAKIURIA 21 0.0005
755 NAUSEA 398 0.0005
756 MEMORY IMPAIRMENT 69 0.0005
757 APHONIA 7 0.0005
758 MUSCLE SPASMS 92 0.0005
759 RENAL IMPAIRMENT 42 0.0005
760 SENSORY DISTURBANCE 8 0.0005
761 INJURY 35 0.0005
762 BONE PAIN 29 0.0005
763 PRESYNCOPE 12 0.0005
764 BODY TEMPERATURE INCREASED 10 0.0005
765 SYNCOPE 49 0.0005
766 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
767 DIZZINESS 243 0.0005
768 NECK PAIN 27 0.0005
769 PEMPHIGUS 6 0.0005
770 FALL 159 0.0005
771 DERMATITIS ALLERGIC 6 0.0005
772 DEPRESSION 107 0.0005
773 CIRCULATORY COLLAPSE 8 0.0005
774 LUNG DISORDER 23 0.0005
775 PROCEDURAL PAIN 13 0.0005
776 GLAUCOMA 9 0.0005
777 ROTATOR CUFF SYNDROME 6 0.0005
778 DEMENTIA 13 0.0005
779 VERTIGO 28 0.0005
780 DEAFNESS 12 0.0005
781 ANGINA PECTORIS 13 0.0005
782 PALPITATIONS 53 0.0005
783 LUNG INFECTION 7 0.0005
784 EYE HAEMORRHAGE 6 0.0004
785 SPINAL FRACTURE 9 0.0004
786 THERAPY PARTIAL RESPONDER 7 0.0004
787 MENINGIOMA 7 0.0004
788 LOSS OF CONSCIOUSNESS 57 0.0004
789 TASTE DISORDER 9 0.0004
790 WEIGHT INCREASED 99 0.0004
791 BLADDER CANCER 26 0.0004
792 FLATULENCE 25 0.0004
793 CORONARY ARTERY OCCLUSION 6 0.0004
794 DYSPNOEA 247 0.0004
795 PLASMA CELL MYELOMA 17 0.0004
796 WHITE BLOOD CELL COUNT DECREASED 47 0.0004
797 BLOOD POTASSIUM INCREASED 7 0.0004
798 DEEP VEIN THROMBOSIS 28 0.0004
799 HAEMOPTYSIS 12 0.0004
800 MOUTH ULCERATION 9 0.0004
801 FEELING ABNORMAL 102 0.0004
802 EPILEPSY 13 0.0004
803 DIPLOPIA 11 0.0004
804 THROAT IRRITATION 19 0.0004
805 VOMITING 198 0.0004
806 SUICIDAL IDEATION 38 0.0004
807 MYELODYSPLASTIC SYNDROME 6 0.0004
808 MENTAL DISORDER 18 0.0004
809 NEURALGIA 10 0.0004
810 ANXIETY 117 0.0004
811 HAEMORRHOIDS 8 0.0004
812 MOVEMENT DISORDER 13 0.0004
813 WHEEZING 24 0.0004
814 MOOD ALTERED 11 0.0004
815 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
816 BLOOD PRESSURE ABNORMAL 8 0.0004
817 BLOOD POTASSIUM DECREASED 12 0.0004
818 CARDIAC FAILURE 32 0.0004
819 SEIZURE 46 0.0004
820 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
821 LACRIMATION INCREASED 12 0.0004
822 CORONARY ARTERY DISEASE 12 0.0004
823 FEELING COLD 11 0.0004
824 DRY MOUTH 32 0.0004
825 FLUID RETENTION 20 0.0004
826 SKIN IRRITATION 18 0.0004
827 DEVICE DIFFICULT TO USE 26 0.0004
828 MUSCLE TWITCHING 9 0.0004
829 DEVICE RELATED INFECTION 6 0.0004
830 DRUG RESISTANCE 10 0.0004
831 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
832 HYPERHIDROSIS 50 0.0004
833 EPISTAXIS 29 0.0004
834 FEMUR FRACTURE 12 0.0004
835 THROMBOCYTOPENIA 43 0.0004
836 BONE DISORDER 7 0.0004
837 HAEMOGLOBIN DECREASED 39 0.0004
838 ILL-DEFINED DISORDER 23 0.0004
839 ULCER 6 0.0004
840 EATING DISORDER 8 0.0004
841 DIABETIC KETOACIDOSIS 9 0.0004
842 ASCITES 11 0.0004
843 FEAR 10 0.0004
844 MENTAL IMPAIRMENT 9 0.0004
845 PRURITUS GENERALISED 8 0.0004
846 BLOOD URINE PRESENT 7 0.0004
847 DEATH 317 0.0004
848 APPLICATION SITE PAIN 8 0.0004
849 OEDEMA PERIPHERAL 44 0.0004
850 INSOMNIA 96 0.0004
851 RASH MACULO-PAPULAR 8 0.0004
852 LIMB DISCOMFORT 11 0.0004
853 HEART RATE IRREGULAR 8 0.0004
854 BLOOD PRESSURE INCREASED 54 0.0004
855 DRUG EFFECT DECREASED 19 0.0004
856 NERVOUS SYSTEM DISORDER 11 0.0004
857 GASTRIC DISORDER 12 0.0003
858 TINNITUS 16 0.0003
859 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
860 INTENTIONAL SELF-INJURY 7 0.0003
861 BLOOD PRESSURE DECREASED 23 0.0003
862 HOT FLUSH 26 0.0003
863 MUSCULOSKELETAL PAIN 18 0.0003
864 APPLICATION SITE ERYTHEMA 9 0.0003
865 COGNITIVE DISORDER 16 0.0003
866 EOSINOPHILIA 6 0.0003
867 COLD SWEAT 6 0.0003
868 SLEEP DISORDER 24 0.0003
869 LEUKOPENIA 17 0.0003
870 LABORATORY TEST ABNORMAL 10 0.0003
871 DRUG DOSE OMISSION 56 0.0003
872 DYSPEPSIA 33 0.0003
873 MUSCULAR WEAKNESS 38 0.0003
874 HEART RATE INCREASED 33 0.0003
875 DECREASED APPETITE 77 0.0003
876 PNEUMONITIS 9 0.0003
877 DRUG EFFECT INCOMPLETE 12 0.0003
878 BLOOD GLUCOSE ABNORMAL 6 0.0003
879 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
880 DRY EYE 16 0.0003
881 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
882 ASTHENIA 120 0.0003
883 GAIT DISTURBANCE 61 0.0003
884 MELAENA 7 0.0003
885 PAIN IN JAW 9 0.0003
886 HYPOCALCAEMIA 6 0.0003
887 GASTRIC ULCER 6 0.0003
888 DEHYDRATION 42 0.0003
889 INCREASED APPETITE 6 0.0003
890 MOOD SWINGS 10 0.0003
891 PULMONARY OEDEMA 14 0.0003
892 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
893 CHOKING 6 0.0003
894 EYE PAIN 17 0.0003
895 JAUNDICE 8 0.0003
896 STOMATITIS 18 0.0003
897 FEEDING DISORDER 6 0.0003
898 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
899 BLOOD PRESSURE FLUCTUATION 7 0.0003
900 RESPIRATORY DISTRESS 8 0.0003
901 AMENORRHOEA 5 0.0003
902 CONSTIPATION 62 0.0003
903 DEPRESSED MOOD 15 0.0003
904 ANAEMIA 54 0.0003
905 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
906 IRRITABILITY 17 0.0003
907 PLATELET COUNT DECREASED 30 0.0003
908 AGEUSIA 7 0.0003
909 CEREBRAL HAEMORRHAGE 10 0.0003
910 POOR QUALITY SLEEP 6 0.0003
911 VISION BLURRED 38 0.0003
912 CARDIOVASCULAR DISORDER 7 0.0003
913 CARDIAC FAILURE CONGESTIVE 22 0.0003
914 RENAL CANCER 13 0.0003
915 TREMOR 45 0.0003
916 RENAL FAILURE 36 0.0003
917 DYSKINESIA 11 0.0003
918 OESOPHAGEAL CARCINOMA 8 0.0003
919 ORAL PAIN 6 0.0003
920 OSTEOPOROSIS 11 0.0003
921 APPLICATION SITE PRURITUS 6 0.0003
922 MOBILITY DECREASED 19 0.0003
923 RHABDOMYOLYSIS 11 0.0003
924 PLEURAL EFFUSION 16 0.0003
925 HAEMATURIA 9 0.0003
926 SHOCK 6 0.0003
927 EYE IRRITATION 15 0.0003
928 BLOOD CREATININE INCREASED 17 0.0003
929 ACUTE RESPIRATORY FAILURE 5 0.0003
930 OEDEMA 14 0.0003
931 DYSPHONIA 15 0.0003
932 MENTAL STATUS CHANGES 7 0.0003
933 AMNESIA 16 0.0002
934 BLINDNESS 10 0.0002
935 OSTEONECROSIS 8 0.0002
936 DYSSTASIA 7 0.0002
937 DYSPNOEA EXERTIONAL 9 0.0002
938 PANCYTOPENIA 13 0.0002
939 HAEMATOMA 6 0.0002
940 HYPOTENSION 46 0.0002
941 BLOOD GLUCOSE INCREASED 43 0.0002
942 DISORIENTATION 9 0.0002
943 EMOTIONAL DISORDER 7 0.0002
944 MENSTRUATION IRREGULAR 6 0.0002
945 CHRONIC KIDNEY DISEASE 17 0.0002
946 CONFUSIONAL STATE 36 0.0002
947 PALLOR 6 0.0002
948 DISEASE PROGRESSION 26 0.0002
949 HYPERGLYCAEMIA 8 0.0002
950 ACCIDENTAL OVERDOSE 8 0.0002
951 TACHYCARDIA 19 0.0002
952 SOMNOLENCE 43 0.0002
953 HYPONATRAEMIA 12 0.0002
954 COMA 10 0.0002
955 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
956 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
957 ACUTE KIDNEY INJURY 31 0.0002
958 HEART RATE DECREASED 7 0.0002
959 APHASIA 6 0.0002
960 NEUTROPENIA 27 0.0002
961 CARDIAC ARREST 16 0.0002
962 ARRHYTHMIA 9 0.0002
963 OCULAR HYPERAEMIA 9 0.0002
964 DYSPHAGIA 18 0.0002
965 URINARY RETENTION 6 0.0002
966 DRUG INTERACTION 28 0.0002
967 SPEECH DISORDER 9 0.0002
968 NEUTROPHIL COUNT DECREASED 7 0.0002
969 COLORECTAL CANCER 8 0.0002
970 BLOOD GLUCOSE DECREASED 8 0.0002
971 RESPIRATORY FAILURE 12 0.0002
972 OXYGEN SATURATION DECREASED 9 0.0002
973 PRODUCT SUBSTITUTION ISSUE 9 0.0002
974 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
975 BALANCE DISORDER 13 0.0002
976 DISTURBANCE IN ATTENTION 8 0.0001
977 DYSGEUSIA 11 0.0001
978 VAGINAL HAEMORRHAGE 6 0.0001
979 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
980 OVERDOSE 27 0.0001
981 INTENTIONAL PRODUCT MISUSE 10 0.0001
982 EMOTIONAL DISTRESS 13 0.0001
983 HALLUCINATION 8 0.0001
984 SUICIDE ATTEMPT 6 0.0001
985 AGITATION 7 0.0001
986 COMPLETED SUICIDE 7 0.0001
987 DRUG ABUSE 6 0.0001
988 NO ADVERSE EVENT 10 0.0001